Pharmaceuticals

Reports by Industry

Research Reports in Pharmaceuticals

Next Generation Sequencing Market
February, 2023

The global Next-generation Sequencing Market was valued at 5.4 billion in 2022 and it is anticipated to grow up to USD 18.7 billion by 2032, at a CAGR of 13.2% during the forecast period. Next-generation sequencing (NGS) is a type… Read More
Single User License
Buy Now

NGS-Based RNA-Sequencing Market 
February, 2023

The global NGS-based RNA Sequencing Market was valued at USD 2.8 Billion in 2022 and it is anticipated to grow up to USD 21.3 Billion by 2032, at a CAGR of 22.5% during the forecast period. NGS-based RNA Sequencing is… Read More
Single User License
Buy Now

Peptic Ulcers – Drug Pipeline Landscape, 2023
February, 2023

Peptic ulcer disease (PUD) is a sore on the lining of the stomach, the first part of the small intestine, or the lower part of the esophagus that is due to the digestive action of pepsin and stomach acid. An… Read More
Single User License
Buy Now

Post-Traumatic Stress Disorder (PTSD) – Drug Pipeline Landscape, 2023
February, 2023

Post-Traumatic Stress Disorder is a mental health condition that’s triggered by either experiencing or observing a horrible event. People who have PTSD may feel stressed or frightened, even when they are not in danger. The main causes of post-traumatic stress… Read More
Single User License
Buy Now

Prenatal and Newborn Genetic Testing Market
February, 2023

The global Prenatal and New-born Genetic Testing Market was valued at USD 4.5 Billion in 2022 and it is anticipated to grow up to USD 20.9 Billion by 2032, at a CAGR of 16.6% during the forecast period. Prenatal testing… Read More
Single User License
Buy Now

Metagenomics Market 
February, 2023

The global Metagenomics Market was valued at USD 1.6 Billion in 2022 and it is anticipated to grow up to USD 6.3 Billion by 2032, at a CAGR of 14.7% during the forecast period. Metagenomics comprises studies that use sequencing… Read More
Single User License
Buy Now

Anaplastic Astrocytoma – Drug Pipeline Landscape, 2023
February, 2023

Anaplastic astrocytoma (AA) is a rare malignant brain tumor or grade III gliomas. This tumor arises from star shaped brain cells called astrocytes. Tumors that arise from glial tissue, including astrocytoma’s, are collectively referred as gliomas. Anaplastic astrocytoma occurs without… Read More
Single User License
Buy Now

Whole Exome Sequencing Market 
February, 2023

The global Whole Exome Sequencing Market was valued at USD 1.4 Billion in 2022 and it is anticipated to grow up to USD 7.4 Billion by 2032, at a CAGR of 18.1% during the forecast period. Exome sequencing is a… Read More
Single User License
Buy Now

Pancreatic Cancer – Drug Pipeline Landscape, 2023
February, 2023

Pancreatic cancer arises when cells in the pancreas begin to grow out in an abnormal form and form a tumor. Pancreatic cancer is classified into the following stages: resectable, borderline resectable, locally advanced, and metastatic. Depending on where the tumour… Read More
Single User License
Buy Now

Progressive Supranuclear Palsy – Drug Pipeline Landscape, 2023
February, 2023

Progressive Supranuclear Palsy is a rare neurodegenerative disease that leads to difficulty with balance, movement, vision, speech, and swallowing. Progressive supranuclear palsy typically begins in late middle age and worsens over time, with severe disability occurring within three to five… Read More
Single User License
Buy Now

Nucleic Acid Amplification Testing Market
February, 2023

The global Nucleic Acid Amplification Testing Market was valued at USD 7.3 Billion in 2022 and it is anticipated to grow up to USD 24.5 Billion by 2032, at a CAGR of 12.8% during the forecast period. A Nucleic Acid… Read More
Single User License
Buy Now

Sanger Sequencing Market
February, 2023

The global Sanger Sequencing Market was valued at USD 1.9 Billion in 2022 and it is anticipated to grow up to USD 13.4 Billion by 2032, at a CAGR of 21.4% during the forecast period. The Sanger technique of DNA… Read More
Single User License
Buy Now

Multiple Sclerosis – Drug Pipeline Landscape, 2023
February, 2023

Multiple Sclerosis (MS) is an autoimmune disorder in which the immune system attacks the myelin sheath that surrounds and protects the nerve fibers, causing inflammation eventually affecting the brain, spinal cord and optic nerves which disrupts the flow of information… Read More
Single User License
Buy Now

Digital Genome Market 
February, 2023

The global Digital Genome Market was valued at USD 28.2 Billion in 2022 and it is anticipated to grow up to USD 64.6 Billion by 2032, at a CAGR of 8.6% during the forecast period. Deep learning is a subset… Read More
Single User License
Buy Now

Gaucher’s Disease – Drug Pipeline Landscape, 2023
February, 2023

Gaucher's disease, or Gaucher disease (GD), is an inherited genetic disorder of the lysosomal storage that is caused by a genetic defect of the lysosomal enzyme "glucocerebrosidase." This enzyme accumulates in cells and certain organs, including the spleen and liver.… Read More
Single User License
Buy Now

Attention Deficit Hyperactivity Disorder (ADHD) – Drug Pipeline Landscape, 2023
February, 2023

Attention Deficit Hyperactivity Disorder (ADHD) is a mental health condition that can cause unusual levels of hyperactivity and impulsive behaviours. People with ADHD may also have trouble focusing their attention on a single task or sitting still for long periods… Read More
Single User License
Buy Now

RNAi Therapeutics Market 
February, 2023

The global RNAi Therapeutics Market was valued at USD 1.4 Billion in 2021 and it is anticipated to grow up to USD 3.8 Billion by 2031, at a CAGR of 10.4% during the forecast period. A brand-new class of drugs… Read More
Single User License
Buy Now

Chemotherapy Induced Neutropenia (CIN) – Drug Pipeline Landscape, 2023
February, 2023

Chemotherapy Induced Neutropenia is a very common side effect of cancer treatment in which the number of neutrophils in the blood drops below a healthy level. Chemotherapy Induced Neutropenia main causes are age, co-morbidities, and time course of therapy. Chemotherapy… Read More
Single User License
Buy Now

Medical Enzyme Technology Market 
January, 2023

The global Medical Enzyme Technology market was valued at USD 3.9 Billion in 2022 and it is anticipated to grow up to USD 7.7 Billion by 2032, at a CAGR of 7.0% during the forecast period. Enzymes play a crucial… Read More
Single User License
Buy Now

Cell Culture Media Market
January, 2023

The global Cell Culture Media Market was valued at 4.2 billion in 2022 and it is anticipated to grow up to USD 12.7 billion by 2032, at a CAGR of 11.7% during the forecast period. Cell culture media is a… Read More
Single User License
Buy Now

Long Read Sequencing Market 
January, 2023

The global Long Read Sequencing Market was valued at 1.5 billion in 2022 and it is anticipated to grow up to USD 6.0 billion by 2032, at a CAGR of 14.8% during the forecast period. DNS is the Domain Name… Read More
Single User License
Buy Now

Small Intestinal Bacterial Overgrowth (SIBO) Diagnostics Market
January, 2023

The global small intestinal bacterial overgrowth diagnostics market was valued at USD 1,38,324.2 Thousand in 2022 and it is anticipated to grow up to USD 2,44,337.1 Thousand by 231.4, at a CAGR of 5.9% during the forecast period. Small intestinal… Read More
Single User License
Buy Now

Histopathology Services Market 
January, 2023

The global Histopathology Services Market was valued at USD 22.8 Billion in 2022 and it is anticipated to grow up to USD 38.4 Billion by 2032, at a CAGR of 5.4% during the forecast period. Histopathology services are used in… Read More
Single User License
Buy Now

Biopreservation Market
January, 2023

The global Biopreservation Market was valued at USD 2.2 Billion in 2022 and it is anticipated to grow up to USD 26.7 Billion by 2032, at a CAGR of 28.5% during the forecast period. Bio-preservative is a technique for preserving… Read More
Single User License
Buy Now

Blood Brain Barrier Technologies Market
January, 2023

The global Blood-Brain Barrier Technologies Market was valued at USD 4.8 Billion in 2022 and it is anticipated to grow up to USD 9.9 Billion by 2032, at a CAGR of 7.5% during the forecast period. Blood-brain barrier (BBB) is… Read More
Single User License
Buy Now